U.S. Chemed, PTC Therapeutics, Regeneron Pharmaceuticals
May 21 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Chemed, PTC Therapeutics and Regeneron Pharmaceuticals, on Tuesday.
HIGHLIGHTS
* Chemed Corp CHE.N: RBC cuts target price to $697 from $712 |
* Deckers Brands DECK.N: Barclays cuts target price to $1,026 from $1,110 |
* PTC Therapeutics Inc PTCT.O: Raymond James raises to market perform from underperform |
* Regeneron Pharmaceuticals Inc REGN.O: Jefferies raises PT to $1,135 from $1,125 |
* United Therapeutics Corp UTHR.O: JP Morgan raises target price to $300 from $280 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Abercrombie & Fitch Co ANF.N: UBS raises target price to $155 from $145 |
* Allogene ALLO.O: Oppenheimer cuts target price to $13 from $14 |
* Alta Equipment Group Inc ALTG.N: D.A. Davidson cuts target price to $20 from $22 |
* Apa Corporation APA.O: Gerdes Energy Research raises target price by $1 to $50 |
* Apa Corporation APA.O: Mizuho raises target price to $35 from $34 |
* Apa Corporation APA.O: Wells Fargo cuts target price to $53 from $55 |
* Astria Therapeutics ATXS.O: Oppenheimer cuts target price to $25 from $29 |
* Avery Dennison Corp AVY.N: BMO raises target price to $256 from $230 |
* Axalta Coating Systems Ltd AXTA.N: Mizuho raises target price to $41 from $38 |
* Blink Charging Co BLNK.O: UBS cuts target price to $4.50 from $7 |
* Boot Barn Holdings Inc BOOT.N: JP Morgan raises target price to $125 from $115 |
* Booz Allen Hamilton Holding Corp BAH.N: Stifel raises target price to $170 from $155 |
* Boyd Gaming Corp BYD.N: Raymond James initiates coverage with outperform rating; PT $67 |
* Caesars Entertainment Inc CZR.O: Raymond James initiates coverage with strong buy rating |
* Caesars Entertainment Inc CZR.O: Raymond James initiates coverage with target price $55 |
* Chemed Corp CHE.N: RBC cuts target price to $697 from $712 |
* Coterra Energy Inc CTRA.N: Wells Fargo cuts target price to $34 from $36 |
* Deckers Outdoor Corp DECK.N: Jefferies raises target price to $825 from $760 |
* Deckers Outdoor Corp DECK.N: Barclays cuts target price to $1026 from $1110 |
* Delek US Holdings Inc DK.N: JP Morgan cuts target price to $25 from $26 |
* Dell Technologies Inc DELL.N: Barclays raises target price to $98 from $94 |
* Dell Technologies Inc DELL.N: Citigroup raises target price to $170 from $125 |
* Dell Technologies Inc DELL.N: Wells Fargo raises target price to $170 from $140 |
* Dick's Sporting Goods Inc DKS.N: TD Cowen cuts target price to $224 from $226 |
* Domo Inc DOMO.O: TD Cowen cuts target price to $10 from $11.50 |
* DXC Technology Co DXC.N: TD Cowen cuts target price to $18 from $22 |
* Dyne Therapeutics Inc DYN.O: Chardan Capital Markets raises target price to $42 from $31 |
* Dyne Therapeutics Inc DYN.O: Guggenheim raises target price to $45 from $37 |
* Ecolab Inc ECL.N: UBS raises target price to $270 from $269 |
* EOG Resources Inc EOG.N: Wells Fargo cuts target price to $140 from $142 |
* EQT Corp EQT.N: Wells Fargo raises target price to $40 from $37 |
* Expedia Group Inc EXPE.O: BTIG cuts target price to $150 from $175 |
* Fedex Corp FDX.N: UBS cuts target price to $333 from $340 |
* First Solar Inc FSLR.O: UBS raises target price to $270 from $252 |
* First Watch Restaurant Group Inc FWRG.O: Guggenheim raises target price to $24 from $23 |
* Fiserv Inc FI.N: Mizuho raises target price to $168.00 from $156.00 |
* Flowers Foods Inc FLO.N: Jefferies raises target price to $24 from $23 |
* HP Inc. HPQ.N: Barclays raises target price to $30 from $24 |
* HP Inc. HPQ.N: Barclays raises to equalweight from underweight |
* Inhibikase Therapeutics, Inc. IKT.O: H.C. Wainwright cuts target price to $23 from $27 |
* Inseego Corp INSG.O: TD Cowen raises target price to $12 from $3.50 |
* Intuit Inc INTU.O: Wells Fargo raises target price to $750 from $725 |
* J M Smucker Co SJM.N: BofA Global Research cuts price objective to $130 from $138 |
* J M Smucker Co SJM.N: JP Morgan cuts target price to $120 from $128 |
* JP Morgan JPM.N: Jefferies raises target price to $230 from $227 |
* JP Morgan JPM.N: KBW raises target price to $209 from $203 |
* JP Morgan Chase & Co JPM.N: UBS raises target price to $224 from $219 |
* Keysight Technologies Inc KEYS.N: Barclays raises target price to $151 from $141 |
* Keysight Technologies Inc KEYS.N: Susquehanna cuts target price to $195 from $208 |
* Kimco Realty Corp KIM.N: Truist Securities cuts target price to $22 from $23 |
* Kirby Corp KEX.N: Stifel raises target price to $132.00 from $131.00 |
* Marathon Oil Corp MRO.N: Wells Fargo cuts target price to $38 from $39 |
* Marqeta Inc MQ.O: Mizuho cuts target price to $7.00 from $8.00 |
* National Vision Holdings Inc EYE.O: BMO cuts target price to $18 from $24 |
* NetApp Inc NTAP.O: Citigroup raises target price to $120 from $110 |
* Newmont NEM.N: BMO cuts target price to $53 from $54 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: JP Morgan raises PT to $20 from $19 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: Stifel raises target price to $26.00 from $25.00 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: UBS raises target price to $19 from $18 |
* Norwegian Cruise Line Holdings Ltd NCLH.N: Wells Fargo raises target to $20 from $19 |
* Ovintiv Inc OVV.N: Wells Fargo cuts target price to $54 from $57 |
* Owens Corning OC.N: RBC raises target price to $201 from $192 |
* Palo Alto Networks Inc PANW.O: Barclays cuts target price to $325 from $345 |
* Palo Alto Networks Inc PANW.O: Bernstein raises target price to $364 from $335 |
* Palo Alto Networks Inc PANW.O: BMO raises target price to $334 from $327 |
* Palo Alto Networks Inc PANW.O: Macquarie raises target price to $285 from $270 |
* Palo Alto Networks Inc PANW.O: RBC cuts target price to $360 from $365 |
* Penn Entertainment Inc PENN.O: Raymond James initiates coverage with outperform rating |
* Penn Entertainment Inc PENN.O: Raymond James initiates coverage with target price $20 |
* PTC Therapeutics Inc PTCT.O: Citigroup raises target price to $26 from $18 |
* PTC Therapeutics Inc PTCT.O: Jefferies raises target price to $46 from $35 |
* PTC Therapeutics Inc PTCT.O: JP Morgan raises target price to $53 from $43 |
* PTC Therapeutics Inc PTCT.O: Raymond James raises to market perform from underperform |
* Pure Storage, Inc. PSTG.N: Barclays cuts to equalweight from overweight |
* Pure Storage, Inc. PSTG.N: Wells Fargo raises target price to $70 from $52 |
* Q32 Bio Inc QTTB.O: Leerink Partners initiates coverage with outperform rating; PT $54 |
* Qualcomm Inc QCOM.O: Benchmark raises target price to $240 from $200 |
* Qualcomm Inc QCOM.O: Rosenblatt Securities raises target price to $240.00 from $200.00 |
* RBC Bearings Inc RBC.N: Truist Securities raises target price to $328 from $309 |
* Regeneron Pharmaceuticals Inc REGN.O: Jefferies raises PT to $1,135 from $1,125 |
* Royal Gold Inc RGLD.O: BMO raises target price to $161 from $160 |
* Rubrik Inc RBRK.N: Citigroup initiates coverage with buy rating; price target $46 |
* Savara Inc SVRA.O: Oppenheimer raises target price to $11 from $9.5 |
* Southstate Corp SSB.N: Raymond James raises to outperform from market perform |
* Spire Global Inc SPIR.N: Raymond James cuts target price to $12 from $14 |
* Syndax Pharmaceuticals Inc SNDX.O: JP Morgan adds stock to its u.s. analyst focus list |
* Teladoc Health Inc TDOC.N: Jefferies cuts target price to $14 from $16 |
* Teladoc Health Inc TDOC.N: JP Morgan cuts target price to $16 from $19 |
* Terex Corp TEX.N: UBS raises target price to $64 from $62 |
* Tyler Technologies Inc TYL.N: Needham raises target price to $600 from $500 |
* Ul Solutions Inc ULS.N: Jefferies raises target price to $44 from $42 |
* Ul Solutions Inc ULS.N: JP Morgan raises target price to $40 from $39 |
* Ul Solutions Inc ULS.N: Wells Fargo raises target price to $43 from $40 |
* United Therapeutics Corp UTHR.O: JP Morgan raises target price to $300 from $280 |
* VF Corp VFC.N: Wedbush cuts target price to $13 from $15.5 |
* Western Midstream Partners LP WES.N: Wells Fargo raises target price to $35 from $34 |
* Wix.Com Ltd WIX.O: Oppenheimer raises target price to $200 from $160 |
* Zoom Video Communications Inc ZM.O: Citigroup raises target price to $77 from $76 |
* Zoom Video Communications Inc ZM.O: Evercore ISI cuts target price to $70 from $72 |
* Zoom Video Communications Inc ZM.O: Stifel cuts target price to $65.00 from $70.00 |
* Zoom Video Communications Inc ZM.O: Wells Fargo cuts target price to $60 from $70 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
